Name | Veramoss |
---|---|
Synonyms |
QR CQ B1 E1 DVO1
EINECS 225-193-0 METHYL 2,4-DIHYDROXY-3,6-DIMETHYLBENZOATE Methyl atratate MFCD00157202 Benzoic acid, 2,4-dihydroxy-3,6-dimethyl-, methyl ester 2,4-Dihydroxy-3,6-dimethylbenzoic acid methyl ester |
Description | Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases[1][2]. |
---|---|
Related Catalog | |
Target |
Androgen receptor, NO synthesis, MAPK-NFκB pathway[1][2] |
In Vitro | Atraric acid (10 μM; CV1 cells) represses the transactivation function mediated by Dihydrotestosterone-induced human AR[1]. Atraric acid (10 μM; PCa cells) inhibits the expression of the PSA gene in both androgen-dependent and androgen-independent PCa cells[1]. Atraric acid (1-300 μM; 24 h) dose-dependently inhibits pro-inflammatory cytokine, nitric oxide, prostaglandin E2 in LPS-stimulated RAW264.7 cells, but does not influence the cell viability[2]. Atraric acid (100 and 300 μM; 18 h or 4 h) downregulates the expression of phosphorylated IκB, extracellular signal-regulated kinases (ERK) and nuclear factor kappa B (NFκB) signaling pathway to exhibit anti-inflammatory effects in LPS-stimulated RAW264.7 cells[2]. Cell Viability Assay[2] Cell Line: RAW264.7 cells Concentration: 1-300 μM Incubation Time: 24 h Result: Did not influence the cell viability. Western Blot Analysis[2] Cell Line: RAW264.7 cells Concentration: 100 and 300 μM Incubation Time: 18 h or 4 h Result: Inhibited LPS-Induced expression of iNOS and COX-2 in a dose-dependent manner. Suppressed LPS-stimulated phosphorylation of the Nfκb signaling pathway. |
In Vivo | Atraric acid (10, 30 mg/kg; i.p.; single dosage) inhibits the production of pro-inflammatory cytokines and reduces pathological damages in LPS-induced endotoxin shock mice[2]. Animal Model: Female BALB/c mice (7 weeks old, 17-20 g; LPS-induced endotoxin shock)[2] Dosage: 10, 30 mg/kg Administration: i.p.; single dosage Result: Inhibited the production of pro-inflammatory cytokines. Reduced pathological damages such as vasodilation and bleeding. |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 360.7±22.0 °C at 760 mmHg |
Melting Point | 141-146 °C(lit.) |
Molecular Formula | C10H12O4 |
Molecular Weight | 196.200 |
Flash Point | 143.9±15.8 °C |
Exact Mass | 196.073563 |
PSA | 66.76000 |
LogP | 2.84 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.570 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
---|---|
Hazard Codes | Xi |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 2 |
HS Code | 2918199090 |
Precursor 10 | |
---|---|
DownStream 10 | |
HS Code | 2918199090 |
---|---|
Summary | 2918199090 other carboxylic acids with alcohol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |